Key Slides

On the Road to an HIV Cure: How Far Have We Come? Alan L. Landay, PhD Cases from the Clinic(ians): Case-Based, Panel Discussion Michael S. Saag, MD Antiretroviral Therapy (ART): New Drugs and New Guidelines Roy M. Gulick, MD, MPH Challenges in the Management and Treatment of HIV/Hepatitis C Virus Coinfection Andrew I. Aronsohn, MD […]

State-of-the-ART in Antiretroviral Therapy: Optimal Initial Regimens in 2016 Rajesh T. Gandhi, MD Changes and Opportunities in Recent Medicaid and Medicare Regulations Rita Vandivort-Warren and Kerri Cornejo, MSW; Kerri Cornego, MPH What’s All the Fuss About the Microbiome? Turner Overton, MD “Everything” You Need to Know About Preexposure Prophylaxis and Postexposure Prophylaxis in 30 Minutes […]

Investigational Approaches to Antiretroviral Therapy Eric S. Daar, MD Sexually Transmitted Diseases: Burning Questions Jeffrey D. Klausner, MD, MPH Update on the 2017 Conference on Retroviruses and Opportunistic Infections Jeffrey L. Lennox, MD Maximizing the Benefits of Preexposure Prophylaxis (PrEP) Susan P. Buchbinder, MD Cases From the Clinic(ians): An Interactive Case-Based Panel Discussion Michael S. […]

Ryan White HIV/AIDS Program Update Laura W. Cheever, MD, ScM HIV Cure and Remission: Questions and a Few Answers Steven G. Deeks, MD Highlights From CROI 2017 and IAS 2017: Focus on Antiretroviral Therapy Joseph J. Eron, MD Antiretroviral Therapy–Interactive Cases From the Clinic(ians): A Case-Based, Panel Discussion Michael S. Saag, MD Strategies for Linkage […]

Antiretroviral Therapy: Case-Based Panel Discussion Rajesh T. Gandhi, MD Moving Into New Frontiers With Solid Organ Transplantation and HIV Christine M. Durand, MD Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy Kristen M. Marks, MD Update on HIV Preexposure Prophylaxis Kenneth H. Mayer, MD